CRINETICS PHARMACEUTICALS IN (CRNX)

US22663K1079 - Common Stock

45.05  +1.23 (+2.81%)

After market: 45.05 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
4.01M4.74M1.08M70.00K1.19M
Operating Expenses
226.62M172.62M108.78M75.02M55.03M
Research and Development
168.53M130.23M84.26M57.00M41.51M
Selling, General, and Administrative Expenses
58.09M42.39M24.53M18.03M13.52M
Operating Income
-222.61M-167.88M-107.70M-74.95M-53.83M
Interest Income/Expense
36.44M32.92M50.00K830.00K3.46M
Other Income/Expense
-23.16M-27.94M10.00K310.00K-50.00K
Income Before Taxes
-209.33M-162.91M-107.64M-73.81M-50.42M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-214.53M-163.92M-107.64M-73.81M-50.42M
EBITDA
-221.51M-166.90M-106.78M-74.00M-52.94M
 
Per Share Data
EPS Diluted Total Ops
-3.69-3.15-2.80-2.42-2.09
Non GAAP EPS
-3.70-3.14-2.80-2.46-2.08
 
Statistics
Profit Margin
-5345.85%-3458.23%-9966.67%-105442.86%-4236.97%
Operating Profit Margin
-5547.17%-3541.77%-9972.22%-107071.43%-4523.53%

All data in USD

Charts